Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them

Details for Australian Patent Application No. 2003255412 (hide)

Owner Merck Patent GmbH

Inventors Ferrand, Gerard; Brunet, Michel; Zeiller, Jean-Jacques; Bonhomme, Yves

Agent Davies Collison Cave

Pub. Number AU-B-2003255412

PCT Number PCT/EP03/08887

PCT Pub. Number WO2004/031116

Priority 0212135 01.10.02 FR

Filing date 11 August 2003

Wipo publication date 23 April 2004

Acceptance publication date 10 September 2009

International Classifications

C07C 67/343 (2006.01) Preparation of carboxylic acid esters

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07C 69/738 (2006.01) Esters of carboxylic acids

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 0212135 01.10.02 FR

27 May 2004 Application Open to Public Inspection

  Published as AU-B-2003255412

10 September 2009 Application Accepted

  Published as AU-B-2003255412

14 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255413-USE OF LCK INHIBITOR FOR TREATMENT OF IMMUNOLOGIC DISEASES

2003255411-ELECTRONIC BRAKE SYSTEM WITH A TEAR FUNCTION